Pharmacovigilance evaluation of the relationship between impaired glucose metabolism and BCR-ABL inhibitor use by using an adverse drug event reporting database-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pharmacovigilance evaluation of the relationship between impaired glucose metabolism and BCR-ABL inhibitor use by using an adverse drug event reporting database

Published:2018-12-18 Issue:1 Volume:8 Page:174-181
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Okada Naoto¹^ORCID,Niimura Takahiro²,Zamami Yoshito¹²,Hamano Hirofumi¹,Ishida Shunsuke¹,Goda Mitsuhiro¹,Takechi Kenshi³,Chuma Masayuki³,Imanishi Masaki¹,Ishizawa Keisuke¹²

Affiliation:

1. Department of Pharmacy; Tokushima University Hospital; Tokushima Japan

2. Department of Clinical Pharmacology and Therapeutics; Tokushima University Graduate School of Biomedical Sciences; Tokushima Japan

3. Clinical Trial Center for Developmental Therapeutics; Tokushima University Hospital; Tokushima Japan

Funder

JSPS KAKENHI

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cam4.1920/fullpdf

Reference34 articles.

1. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome;Druker;N Engl J Med,2001

2. Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia;Druker;N Engl J Med,2006

3. Nilotinib versus imatinib for the treatment of patients with newly diagnosed chronic phase, Philadelphia chromosome-positive, chronic myeloid leukaemia: 24-month minimum follow-up of the phase 3 randomised ENESTnd trial;Kantarjian;Lancet Oncol,2011

4. Dasatinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukemia;Kantarjian;N Engl J Med,2010

5. Ponatinib in refractory Philadelphia chromosome-positive leukemias;Cortes;N Engl J Med,2012

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between age and onset of daptomycin-induced adverse events using the U.S. food and drug administration adverse event reporting system;Journal of Infection and Chemotherapy;2024-08

2. Pharmacovigilance Study on Eosinophilic Pneumonia Induced by Anti-MRSA Agents: Analysis Based on the FDA Adverse Event Reporting System;Open Forum Infectious Diseases;2023-08-01

3. Disproportionality Analysis on Hypothyroidism With Roxadustat Using the Japanese Adverse Drug Event Database;The Journal of Clinical Pharmacology;2023-07-26

4. Risk of delirium with antiepileptic drug use: a study based on the Japanese Adverse Drug Event Report database;International Journal of Clinical Pharmacy;2023-03-28

5. Analysis of Clinical Factors in Olaparib-related Anemia Using Adverse Drug Event Reporting Databases;Anticancer Research;2023-01-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3